The current XBIO market cap is 6.3M. The company's latest EPS is USD -2.6839 and P/E is -1.54.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 414k | 487k | 606k | 651k | 611k |
Operating Income | -848k | -1.56M | -915k | -1.2M | -1.15M |
Net Income | -804k | -1.48M | -857k | -1.05M | -1.06M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 17k | 437k | 1.16M | 1.71M | 2.54M |
Operating Income | -12.89M | -13.94M | -5.75M | -6.72M | -4.52M |
Net Income | -18.06M | -10.89M | -5.65M | -6.55M | -4.14M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 15.57M | 14.72M | 13.72M | 12.75M | 11.96M |
Total Liabilities | 1.05M | 1.07M | 856k | 871k | 1.07M |
Total Equity | 14.52M | 13.65M | 12.86M | 11.88M | 10.89M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 21.55M | 13.18M | 19.82M | 14.72M | 10.61M |
Total Liabilities | 4.33M | 963k | 1.42M | 1.07M | 809k |
Total Equity | 17.21M | 12.22M | 18.39M | 13.65M | 9.8M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -3.9M | -4.65M | -1.1M | -2.37M | -3.32M |
Investing | -500k | -500k | N/A | N/A | N/A |
Financing | N/A | N/A | N/A | N/A | N/A |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -6.4M | -4.27M | -4.74M | -4.65M | -4.11M |
Investing | 2k | N/A | N/A | -500k | N/A |
Financing | 16.13M | 5.43M | 11.45M | N/A | N/A |
Market Cap | 6.3M |
Price to Earnings Ratio | -1.54 |
Price to Sales Ratio | 2.51 |
Price to Cash Ratio | 0.71 |
Price to Book Ratio | 0.65 |
Dividend Yield | - |
Shares Outstanding | 1.54M |
Average Volume (1 week) | 2.57k |
Average Volume (1 Month) | 6.88k |
52 Week Change | -11.49% |
52 Week High | 5.97 |
52 Week Low | 2.55 |
Spread (Intraday) | 0.36 (8.72%) |
Company Name | Xenetic Biosciences Inc |
Address |
3273 e warm springs road las vegas, nevada 89120 |
Website | https://www.xeneticbio.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.